This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Mathew J, Kratzke RA. Lung cancer and lung transplantation: a review. J Thorac Oncol 2009; 4: 753-60. doi: 10.1097/JTO.0b013e31819afdd9MathewJKratzkeRALung cancer and lung transplantation: a reviewJ Thorac Oncol200947536010.1097/JTO.0b013e31819afdd9Open DOISearch in Google Scholar
Choi YH, Leung AN, Miro S, Poirier C, Hunt S, Theodore J. Primary bronchogenic carcinoma after heart or lung transplantation: radiologic and clinical findings. J Thorac Imaging 2000; 15: 36-40.ChoiYHLeungANMiroSPoirierCHuntSTheodoreJPrimary bronchogenic carcinoma after heart or lung transplantation: radiologic and clinical findingsJ Thorac Imaging200015364010.1097/00005382-200001000-00008Search in Google Scholar
Raviv Y, Shitrit D, Amital A, Fox B, Rosengarten D, Fruchter O, et al. Lung cancer in lung transplant recipients: experience of a tertiary hospital and literature review. Lung Cancer 2011; 74: 280-3. doi: 10.1016/j.lungcan.2011.02.012RavivYShitritDAmitalAFoxBRosengartenDFruchterOet alLung cancer in lung transplant recipients: experience of a tertiary hospital and literature reviewLung Cancer201174280310.1016/j.lungcan.2011.02.012Open DOISearch in Google Scholar
Du L, Pennell NA, Elson P, Hashemi-Sadraei N. Lung cancer treatment outcomes in recipients of lung transplant. Transl Lung Cancer Res 2015; 4: 784-91. doi: 10.3978/j.issn.2218-6751.2015.12.08DuLPennellNAElsonPHashemi-SadraeiNLung cancer treatment outcomes in recipients of lung transplantTransl Lung Cancer Res201547849110.3978/j.issn.2218-6751.2015.12.08Open DOISearch in Google Scholar
Collins J, Kazerooni EA, Lacomis J, McAdams HP, Leung AN, Shiau M, et al. Bronchogenic carcinoma after lung transplantation: frequency, clinical characteristics, and imaging findings. Radiology 2002; 224: 131-8. doi: 10.1148/ radiol.2241011189CollinsJKazerooniEALacomisJMcAdamsHPLeungANShiauMet alBronchogenic carcinoma after lung transplantation: frequency, clinical characteristics, and imaging findingsRadiology2002224131810.1148/radiol.2241011189Open DOISearch in Google Scholar
Dickson RP, Davis RD, Rea JB, Palmer SM. High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant 2006; 25: 1297-301. doi: 10.1016/j.healun.2006.09.009DicksonRPDavisRDReaJBPalmerSMHigh frequency of bronchogenic carcinoma after single-lung transplantationJ Heart Lung Transplant200625129730110.1016/j.healun.2006.09.009Open DOISearch in Google Scholar
Timmerman RD, Hu C, Michalski J, Straube W, Galvin J, Johnstone D, et al. Long-term results of RTOG 0236: a phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2014; 90: S30. doi: 10.1016/j.ijrobp.2014.05.135TimmermanRDHuCMichalskiJStraubeWGalvinJJohnstoneDet alLong-term results of RTOG 0236: a phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I non-small cell lung cancerInt J Radiat Oncol Biol Phys201490S3010.1016/j.ijrobp.2014.05.135Open DOISearch in Google Scholar
Fitton TP, Bethea BT, Borja MC, Yuh DD, Yang SC, Orens JB, et al. Pulmonary resection following lung transplantation. Ann Thorac Surg 2003; 76: 1680-6. doi: 10.1016/s0003-4975(03)00975-5FittonTPBetheaBTBorjaMCYuhDDYangSCOrensJBet alPulmonary resection following lung transplantationAnn Thorac Surg2003761680610.1016/s0003-4975(03)00975-5Open DOISearch in Google Scholar
Nyman J, Hallqvist A, Lund J-A, Brustugun OT, Bergman B, Bergström P, et al. SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiother Oncol 2016; 121: 1-8. doi: 10.1016/j.radonc.2016.08.015NymanJHallqvistALundJ-ABrustugunOTBergmanBBergströmPet alSPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLCRadiother Oncol20161211810.1016/j.radonc.2016.08.015Open DOISearch in Google Scholar
Ball D, Mai GT, Vinod S, Babington S4, Ruben J5, Kron T, et al. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol 2019; 20: 494-503. doi: 10.1016/S1470-2045(18)30896-9BallDMaiGTVinodSBabingtonS4RubenJ5KronTet alStereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trialLancet Oncol20192049450310.1016/S1470-2045(18)30896-9Open DOISearch in Google Scholar
Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 2015; 16: 630-7. doi: 10.1016/S1470-2045(15)70168-3ChangJYSenanSPaulMAMehranRJLouieAVBalterPet alStereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsLancet Oncol201516630710.1016/S1470-2045(15)70168-3Open DOISearch in Google Scholar
Zheng X, Schipper M, Kidwell K, Lin J, Reddy R, Ren Y, et al. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis. Int J Radiat Oncol Biol Phys 2014; 90: 60311. doi: 10.1016/j.ijrobp.2014.05.055ZhengXSchipperMKidwellKLinJReddyRRenYet alSurvival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysisInt J Radiat Oncol Biol Phys2014906031110.1016/j.ijrobp.2014.05.055Open DOISearch in Google Scholar
Ros J, Matos I, Martin-Liberal J. Immunotherapy in organ-transplanted cancer patients: efficacy and risk of organ rejection. Ann Oncol 2019; 30: 1173-7. doi: 10.1093/annonc/mdz129RosJMatosIMartin-LiberalJImmunotherapy in organ-transplanted cancer patients: efficacy and risk of organ rejectionAnn Oncol2019301173710.1093/annonc/mdz129Open DOISearch in Google Scholar
Walle T, Martinez Monge R, Cerwenka A, Ajona D, Melero I, Lecanda F. Radiation effects on antitumor immune responses: current perspectives and challenges. Ther Adv Med Oncol 2018; 10: 1758834017742575. doi: 10.1177/1758834017742575WalleTMartinezMonge RCerwenkaAAjonaDMeleroILecandaFRadiation effects on antitumor immune responses: current perspectives and challengesTher Adv Med Oncol201810175883401774257510.1177/1758834017742575Open DOISearch in Google Scholar
Fleming CW, Stephans KL, Broughman JR, Rybicki L, Budev M, Ahmad U, et al. Outcomes after SBRT for inoperable early stage lung cancers arising in organ transplant patients. Int J Radiat Oncol Biol Phys 2019; 105: E486. doi: 10.1016/j.ijrobp.2019.06.1382FlemingCWStephansKLBroughmanJRRybickiLBudevMAhmadUet alOutcomes after SBRT for inoperable early stage lung cancers arising in organ transplant patientsInt J Radiat Oncol Biol Phys2019105E48610.1016/j.ijrobp.2019.06.1382Open DOISearch in Google Scholar
Chen H, Tikkanen J, Boldt RG, Louie A V. Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation. Radiat Oncol 2018; 13: 142. doi: 10.1186/s13014-018-1089-8ChenHTikkanenJBoldtRGLouieA VStereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantationRadiat Oncol20181314210.1186/s13014-018-1089-8Open DOISearch in Google Scholar
